Trial Profile
Chemotherapy plus Ofatumumab at Standard or Mega dose In Chronic lymphoid leukemia (CLL)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2023
Price :
$35
*
At a glance
- Drugs Ofatumumab (Primary) ; Bendamustine; Cyclophosphamide; Cyclophosphamide; Fludarabine; Fludarabine
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- Acronyms COSMIC
- 15 Dec 2021 Status changed from active, no longer recruiting to completed.
- 25 Jun 2017 Primary endpoint (Proportion of patients achieving a Complete Response) has not been met, according to the abstract presented at the 22nd Congress of the European Haematology Association.
- 25 Jun 2017 Results presented at the 22nd Congress of the European Haematology Association.